What do you see coming on a positive side happening next week and in the near term? Nearly the entire OS trade recently at rising prices up to .36/share, and then $12 Mil cash raised from an institution at .25/share , before this R/S.
Makes me wonder why? Are the last of the weak hand shares being taken off the market for a 5X rally on news in weeks to raise cash at $10/share?
That is how these biotechs games are played...
Gotta buy the knife at the bottom and sit...and wait...
The risk side is debt, negative working capital? But they do have a pile of cash and reduced operating costs.